About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5905195
Allelic
Composition
Lrrc10tm1Sgt/Lrrc10tm1Sgt
Genetic
Background
B6.129P2-Lrrc10tm1Sgt
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Lrrc10tm1Sgt mutation (0 available); any Lrrc10 mutation (20 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• increase in length of cardiomyocytes without change in cell width, suggesting eccentric cardiac growth
• enlarged hearts at 4 and 10 months of age with wet heart weight-to-body weight ratios increased
• hearts show induction of fetal genes Nppa, Myh7 and Nppb, indicating cardiac hypertrophy
• left ventricular chamber dilation in adults
• early-onset cardiomyopathy that develops into dilated cardiomyopathy by 1 month of age
• hearts develop dilated phenotype showing a reduction in the ratio of left ventricular wall and septal thickness to left ventricle chamber radius which indicates eccentric cardiac growth
• however, no concentric hypertrophic growth or left ventricle wall thickening is seen, no changes in heart rate or mitral and aortic valve function are seen, no myocyte disarray or fibrosis, or cardiomyocyte proliferation and apoptosis alterations are seen
• systolic dysfunction with increases in left ventricular inner diameter at end diastole and end systole within one month of age
• decrease in fractional shortening at all ages examined, indicating defective cardiac function during perinatal and postnatal life
• systolic function impairment is seen as early as E17.5
• however, intraventricular septal or left ventricle posterior wall thickness is not changed
• passive force generation at a given sarcomere length in trabecular myocardium is similar to controls and myofilament calcium sensitivity is unaltered

mortality/aging
N
• mice exhibit normal life span

muscle
• increase in length of cardiomyocytes without change in cell width, suggesting eccentric cardiac growth
• early-onset cardiomyopathy that develops into dilated cardiomyopathy by 1 month of age
• hearts develop dilated phenotype showing a reduction in the ratio of left ventricular wall and septal thickness to left ventricle chamber radius which indicates eccentric cardiac growth
• however, no concentric hypertrophic growth or left ventricle wall thickening is seen, no changes in heart rate or mitral and aortic valve function are seen, no myocyte disarray or fibrosis, or cardiomyocyte proliferation and apoptosis alterations are seen
• systolic dysfunction with increases in left ventricular inner diameter at end diastole and end systole within one month of age
• decrease in fractional shortening at all ages examined, indicating defective cardiac function during perinatal and postnatal life
• systolic function impairment is seen as early as E17.5
• however, intraventricular septal or left ventricle posterior wall thickness is not changed
• passive force generation at a given sarcomere length in trabecular myocardium is similar to controls and myofilament calcium sensitivity is unaltered

growth/size/body
• enlarged hearts at 4 and 10 months of age with wet heart weight-to-body weight ratios increased
• hearts show induction of fetal genes Nppa, Myh7 and Nppb, indicating cardiac hypertrophy

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
dilated cardiomyopathy DOID:12930 OMIM:PS115200
J:195548


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory